This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Jory Lietard
Associate Professor at University of Vienna
Speaker

Profile

Dr. Jory Lietard received his PhD in 2012 at the University of Bern (Switzerland) under the supervision of Prof. Christian Leumann, working on oligonucleotide therapeutics. With a research fellowship awarded by the Swiss National Science Foundation, he then joined the lab of Prof. Masad Damha at McGill University (Canada) in 2013 as a post-doctoral student, focusing on developing new chemistry for FANA and RNA synthesis. In 2015, he joined the group of Prof. Mark Somoza at the University of Vienna (Austria) where he started to focus on the synthesis of nucleic acid microarrays, developing the first chemical synthesis of RNA microarrays. He became PI in 2020 and Assistant Professor of Nucleic Acid Chemistry in 2024 at the University of Vienna. His research interests focus on microarray synthesis, oligonucleotide and bioorganic chemistry, biotechnology, chemical biology, DNA data storage. He is a member of the Austrian Chemical Society (GÖCH) and the German Nucleic Acid Chemistry Society (DNG). He is the recipient of multiple research grants from the Austrian Science Fund and has published close to 40 scientific articles.